Literature DB >> 19641137

GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway.

Myeung Su Lee1, Hun Soo Kim, Jeong-Tae Yeon, Sik-Won Choi, Churl Hong Chun, Han Bok Kwak, Jaemin Oh.   

Abstract

Osteoclasts are multinucleated cells that are formed by the fusion of mononuclear osteoclasts, which is an essential process in bone resorption leading to bone remodeling. Herein we show that GM-CSF promoted the fusion of prefusion osteoclasts (pOCs). The expression of GM-CSF receptor-alpha was significantly up-regulated at the fusion stage of pOCs induced by RANKL. GM-CSF induced the expression of dendritic cell-specific transmembrane protein (DC-STAMP), which was mediated by inducing NFATc1 via induction of c-Fos. The expression of c-Fos and NFATc1 was regulated by the ERK signaling pathway. Inhibition of ERK and NFATc1 suppressed the expression of DC-STAMP and led to the fusion inhibition of pOC. However, retrovirus-mediated expression of NFATc1 in pOCs rescued the defect in pOC fusion, despite the presence of U0126 and cyclosporin A. GM-CSF-stimulated pOCs had an intact actin ring and could resorb bone. Importantly, pOCs infected with constitutively active MEK adenovirus expressed c-Fos and NFATc1, followed by the binding of NFATc1 to the DC-STAMP promoter, which enables its transcription and expression. Constitutively active MEK-infected pOCs are able to resorb bone by undergoing cell-cell fusion. Taken together, our results demonstrated that GM-CSF induced fusion of pOCs to form multinucleated osteoclasts, making the osteoclast capable of bone resorption.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19641137     DOI: 10.4049/jimmunol.0804314

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  Simvastatin inhibits lipopolysaccharide-induced osteoclastogenesis and reduces alveolar bone loss in experimental periodontal disease.

Authors:  J Jin; X Zhang; Z Lu; Y Li; M F Lopes-Virella; H Yu; C J Haycraft; Q Li; K L Kirkwood; Y Huang
Journal:  J Periodontal Res       Date:  2013-10-07       Impact factor: 4.419

2.  The adaptor protein p62 is involved in RANKL-induced autophagy and osteoclastogenesis.

Authors:  Rui-Fang Li; Gang Chen; Jian-Gang Ren; Wei Zhang; Zhong-Xing Wu; Bing Liu; Yi Zhao; Yi-Fang Zhao
Journal:  J Histochem Cytochem       Date:  2014-08-27       Impact factor: 2.479

3.  Simvastatin inhibits LPS-induced alveolar bone loss during metabolic syndrome.

Authors:  J Jin; E R Machado; H Yu; X Zhang; Z Lu; Y Li; M F Lopes-Virella; K L Kirkwood; Y Huang
Journal:  J Dent Res       Date:  2013-12-18       Impact factor: 6.116

4.  Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone.

Authors:  Jumpei Teramachi; Hua Zhou; Mark A Subler; Yukiko Kitagawa; Deborah L Galson; David W Dempster; Jolene J Windle; Noriyoshi Kurihara; G David Roodman
Journal:  J Bone Miner Res       Date:  2014-06       Impact factor: 6.741

5.  Increased inflammation and disease activity among current cigarette smokers with rheumatoid arthritis: a cross-sectional analysis of US veterans.

Authors:  Jeremy Sokolove; Catriona A Wagner; Lauren J Lahey; Harlan Sayles; Michael J Duryee; Andreas M Reimold; Gail Kerr; William H Robinson; Grant W Cannon; Geoffrey M Thiele; Ted R Mikuls
Journal:  Rheumatology (Oxford)       Date:  2016-07-31       Impact factor: 7.580

6.  Gene expression changes in cancellous bone of type 2 diabetics: a biomolecular basis for diabetic bone disease.

Authors:  A T Haug; K F Braun; S Ehnert; L Mayer; U Stöckle; A K Nüssler; S Pscherer; T Freude
Journal:  Langenbecks Arch Surg       Date:  2014-04-10       Impact factor: 3.445

7.  Biological responses of human mesenchymal stem cells to titanium wear debris particles.

Authors:  Hana Haleem-Smith; Evan Argintar; Curtis Bush; Daniel Hampton; William F Postma; Faye H Chen; Todd Rimington; Joshua Lamb; Rocky S Tuan
Journal:  J Orthop Res       Date:  2011-11-14       Impact factor: 3.494

Review 8.  Alternative pathways of osteoclastogenesis in inflammatory arthritis.

Authors:  Iannis E Adamopoulos; Elizabeth D Mellins
Journal:  Nat Rev Rheumatol       Date:  2014-11-25       Impact factor: 20.543

9.  The 1,2,3-triazole derivative KP-A021 suppresses osteoclast differentiation and function by inhibiting RANKL-mediated MEK-ERK signaling pathway.

Authors:  Hye Jung Ihn; Doohyun Lee; Taeho Lee; Hong-In Shin; Yong Chul Bae; Sang-Hyun Kim; Eui Kyun Park
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-13

Review 10.  Osteoclasts-Key Players in Skeletal Health and Disease.

Authors:  Deborah Veis Novack; Gabriel Mbalaviele
Journal:  Microbiol Spectr       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.